Document is current
Any future updates will be listed below
-
Authors
Frias, Alex
Di Leo, Luca https://orcid.org/0000-0002-2419-2196
Antoranz, Asier
Nazerai, Loulieta https://orcid.org/0000-0002-1090-9029
Carretta, Marco
Bodemeyer, Valérie
Pagliuca, Chiara https://orcid.org/0000-0002-1694-0342
Dahl, Christina
Claps, Giuseppina
Mandelli, Giulio Eugenio
Andhari, Madhavi Dipak
Pacheco, Maria Pires
Sauter, Thomas
Robert, Caroline
Guldberg, Per
Madsen, Daniel Hargbøl
Cecconi, Francesco
Bosisio, Francesca Maria
De Zio, Daniela https://orcid.org/0000-0002-9454-402X
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04158583 at ClinicalTrials.govDocuments that mention this clinical trial
Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma
https://doi.org/10.1136/jitc-2022-006389
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
https://doi.org/10.1136/jitc-2021-002591
-
Funding
Funding for this research was provided by:
NEYE foundation (N/A)
Danmarks Grundforskningsfond (DNRF125)
Melanoma Research Alliance (MRA 620385)
Lundbeck Foundation (R307-2018-3326)
Danish Cancer Society (R204-A12424)
Danish Cancer Society (R231-A14035)
LEO Foundation (LF-OC-19-000004)
- License Information
